Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 109 days ( -73.65 % )
Last Price $8.37 0 %
High/ Low $8.37 - $8.37 0%
Chg 7 Days N/A $8.37 $8.37
Chg 30 Days N/A $8.37 $8.37
Chg 12 mos 42.35 % $5.88 $8.37
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 61.61 % Width: 71.50 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $9.98 - $17.12 19.26 % - 104.54 %
Short MA avg 3 mos Buy 2023-03-09 - 57 days
Long MA avg 3 mos Buy 2023-04-19 - 29 days
Short/Long MA avg 3 mos Buy 2023-04-19 - 29 days
Short MA avg 12 mos Buy 2023-03-16 - 52 days
Long MA avg 12 mos Buy 2022-12-29 - 104 days
Short/Long MA avg 12 mos Buy 2023-01-09 - 98 days
Pivot Short Sell 2023-05-26 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Concert Pharmaceuticals

Concert Pharmaceuticals Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologi... CNCE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT